title: The characterization, localization and regulation of endothelin in ovine pars intermedia.
abstract: The pituitary intermediate lobe (IL) contains a single population of cells and has recently been shown to express endothelin (ET)-like peptides. The IL thus provides an excellent in vivo model to study regulation, function and processing of ET in an endocrine cell. The primary aims of the present study were to locate and characterize the precise molecular forms of ET in the ovine IL and determine if levels and/or processing of ET is under dopaminergic or other influences. We have developed a radioimmunoassay (RIA) that detects each form of ET and, when combined with reverse phase-HPLC (RP-HPLC), shows the ovine IL to contain predominantly the ET-1 isoform. In addition, using a specific anti-endothelin antiserum for immunohistochemistry (IHC), we localized ET-1 with alpha-melanocyte stimulating hormone (alpha-MSH) within the melanotroph. The effects of dopamine agonists, antagonists and hypothalamo-pituitary disconnection (HPD) on both tissue levels and processing of ET in the ovine IL were also examined. Normal sheep were treated chronically with haloperidol or bromocriptine to investigate the possibility of dopaminergic regulation of ET in the IL. In the haloperidol-treated group, plasma prolactin levels did not vary significantly from day 0 to day 8, but the bromocriptine treatment reduced prolactin levels (t = 9.4 P < 0.01). Neither bromocriptine nor haloperidol, however, affected tissue ET peptide levels or forms. After HPD, the HPLC profile of pooled IL showed that ET-1 levels in the IL are slightly increased with no change in molecular forms.
authors.affiliation: Baker Medical Research Institute, Prahran, Victoria, Australia.
authors.forename: V M
authors.initials: VM
authors.lastname: Mansour
authors.forename: I J
authors.initials: IJ
authors.lastname: Clarke
authors.forename: A I
authors.initials: AI
authors.lastname: Smith
mesh_terms: D000818:Animals; D002851:Chromatography, High Pressure Liquid; D018491:Dopamine Agonists / Q000494:pharmacology*; D018492:Dopamine Antagonists / Q000494:pharmacology*; D019332:Endothelin-1 / Q000032:analysis / Q000378:metabolism; D019333:Endothelin-2 / Q000032:analysis / Q000378:metabolism; D019334:Endothelin-3 / Q000032:analysis / Q000378:metabolism; D016232:Endothelins / Q000032:analysis / Q000378:metabolism*; D007150:Immunohistochemistry; D010902:Pituitary Gland / Q000737:chemistry / Q000378:metabolism* / Q000601:surgery; D012756:Sheep
chemical_list: D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D019332:Endothelin-1; D019333:Endothelin-2; D019334:Endothelin-3; D016232:Endothelins